513-985-0088
Cardiology
Ian J. Sarembock, MB CHB
|
|
Give Review
Ian J. Sarembock, MB CHB practices Cardiology. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Sarembock is a published doctor. He has 96 publications published. The most current publication "Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention." He is registered with Medicare.
Publications
- Use of the REG1 anticoagulation system in patients with Acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
- Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?
- Accelerated atherosclerosis in apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.
- From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery.
- CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.
- The truth and consequences of the COURAGE trial.
- Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1.
- Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.
- Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic Myocardial perfusion imaging for determining lesion signi...
- Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis.
- High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity.
- Outcome of patients with Acute coronary syndromes and moderate coronary lesions undergoing deferral of revascularization based on fractional flow reserve assessment.
- Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main Coronary artery disease.
- Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice.
- Fractional flow reserve of infarct-related Arteries identifies reversible defects on noninvasive myocardial perfusion imaging early after myocardial infarction.
- Lymphocyte recruitment into the Aortic wall before and during development of atherosclerosis is partially L-selectin dependent.
- Predictors of vascular complications post diagnostic cardiac catheterization and percutaneous Coronary interventions.
- Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice.
- Use of bivalirudin during percutaneous Coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous Coronary in...
- The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis.
- Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coro...
- Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
- Phosphorylation regulates Id3 function in vascular smooth muscle cells.
- Critical role of platelet P-selectin in the response to arterial injury in apolipoprotein-E-deficient mice.
- Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial Coronary arteries.
- Effect of Acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing.
- Percutaneous treatment of focal vs. diffuse in-stent restenosis: a prospective randomized comparison of conventional therapies.
- Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus.
- Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
- Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient m...
- Treatment effects of eptifibatide in planned Coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).
- Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury.
- Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native Coronary narrowings of moderate severity.
- Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.
- Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing Coronary intervention.
- Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone: potential implications for dosing of antithrombin age...
- Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine Coronary arteries.
- Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits.
- Cardiogenic shock: therapy and prevention.
- A new single-injury model of balloon angioplasty in cholesterol-fed rabbits: beneficial effect of hirudin and comparison with double-injury model.
- alpha-Thrombin induces transforming growth factor-beta1 mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor.
- Remodeling rather than neointimal formation?
- Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin.
- Myocardial contrast echocardiography demonstrates that collateral flow can preserve myocardial function beyond a chronically occluded Coronary artery.
- Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis.
- Aortocaval fistula complicating abdominal aortic Aneurysm: case report and literature review.
- Effectiveness of hirulog in reducing restenosis after balloon angioplasty of atherosclerotic femoral Arteries in rabbits.
- Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits.
- Effects of late (1 to 30 days) reperfusion after Acute myocardial infarction on the signal-averaged electrocardiogram.
- Thrombin stimulates proliferation of cultured rat Aortic smooth muscle cells by a proteolytically activated receptor.
- Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA.
- Microvascular integrity indicates myocellular viability in patients with recent Myocardial infarction. New insights using Myocardial contrast echocardiography.
- Response of femoral Arteries of cholesterol-fed rabbits to balloon angioplasty with or without laser: emphasis on the distribution of foam cells.
- Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral Arteries in rabbits.
- Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic-histomorphometric studie...
- Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after Coronary balloon angioplasty.
- Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal Coronary angioplasty.
- Effect of midinfrared holmium: YAG laser angioplasty with and without balloon angioplasty on Acute outcome and restenosis in atherosclerotic femoral arteries in rabbits.
- Thrombin-induced mitogenesis in cultured Aortic smooth muscle cells requires prolonged thrombin exposure.
- Value of radiographic evidence of calcification of the Aortic valve in adults with basal systolic ejection murmurs.
- Tachycardia-induced reversible left ventricular dysfunction. A report of 2 cases.
- Use of venous contrast echocardiography for diagnosis of cardiac tamponade.
- Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit.
- Vascular reactivity after balloon angioplasty in an atherosclerotic rabbit.
- Myocardial infarction in a patient with factor XI deficiency and a lupus anticoagulant.
- Ampicillin remains inadequate therapy for enterococcal Endocarditis.
- Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral Arteries in rabbits.
- Effects of serotonin-receptor blockade on angioplasty-induced vasospasm in an atherosclerotic rabbit model.
- Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit.
- Usefulness of dynamic hand exercise for developing maximal separation of left and right ventricular pressures at end-diastole and usefulness in distinguishing restrict...
- An association between collateral blood flow and Myocardial viability in patients with recent Myocardial infarction.
- Effect of chronic subcutaneous or intramural administration of heparin on femoral Artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quanti...
- Comparison of bivalirudin versus heparin during percutaneous Coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLA...
- Alpha4beta1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following Carotid injury in apolipoprotein E (-/-) mice.
- Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous Coronary rev...
- LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury.
- Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3.
- Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.
- Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous Coronary intervention: ...
- The role of inflammation in vascular injury and repair.
- Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous Coronary interventions? No.
- The role of inflammation in vascular Diseases.
- Induction of IG9 monocyte adhesion molecule expression in smooth muscle and endothelial cells after balloon arterial injury in cholesterol-fed rabbits.
- All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit : a favorable effect on vessel remodeling.
- Arterial injury increases expression of inflammatory adhesion molecules in the Carotid arteries of apolipoprotein-E-deficient mice.
- Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model.
- Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful Coronary intervention.
- In-hospital costs of Coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.
- Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine Carotid ligation model.
- Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.
- Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.
- Relationship between extent of residual myocardial viability and Coronary flow reserve in patients with recent myocardial infarction.
- Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice.
- Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the Carotid artery of the apolipoprotein-E null mouse.
- P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver.
Schools
University of Cape Town Faculty of Health Sciences
Groote Schuur Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- Pathway X Bronze Direct CACA IN HIX
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Managed Care (Non-HMO)
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- Medico
- Molina
- Mutual of Omaha
- MVP Health Care
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Yale-New Haven Hospital -
University of Cape Town Faculty of Medicine
Hospital
-
Christ Hospital
Drug Facts
| NPI NUMBER | 1922198613 | |
| NPPES Provider LastName | SAREMBOCK | |
| NPPES Provider FirstName | IAN | |
| NPPES Provider ZIPCode | 452192906 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 3423.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922198613 |
| Last Name Of The Provider | SAREMBOCK |
| First Name Of The Provider | IAN |
| View All |